1-3 of 3
Timothy J Littlewood
Close
Sort by
Journal Articles

ABO Blood Group Mismatch Does Not Affect Survival Or Transfusion Requirements In Patients Undergoing Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation

Charlotte K Brierley, Timothy J Littlewood, Andrew Peniket, Richard Gregg, Janice Ward, Andrew Clark, Anne Parker, Ram Malladi, Patrick G Medd
Journal: Blood
Blood (2013) 122 (21): 3352.
https://doi.org/10.1182/blood.V122.21.3352.3352
Published: 2013
Journal Articles

Allogeneic and Syngeneic Hematopoietic Cell Transplants in Patients with AL-Amyloidosis: A Report from the European Group for Blood and Marrow Transplantation (EBMT).

Stefan O. Schoenland, M.D., Michel Baccarani, M.D., Andrew Campbell, M.D., Enric Carreras, M.D., Catherine Cordonnier, M.D., Leanthe Grommisch, M.D., Veronique Leblond, M.D., Timothy J. Littlewood, M.D., Leo F. Verdonck, M.D., L. Wood, M.D., Pierre Zachee, M.D., Axel R. Zander, M.D., Hartmut Goldschmidt, M.D., Dietger Niederwieser, M.D., Goesta Gahrton, M.D.
Journal: Blood
Blood (2004) 104 (11): 5133.
https://doi.org/10.1182/blood.V104.11.5133.5133
Published: 2004
Journal Articles

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase

Clinical Trials & Observations Brief Report
Jackie Boultwood, Andrew Peniket, Fiona Watkins, Patricia Shepherd, Paul McGale, Susan Richards, Carrie Fidler, Timothy J. Littlewood, James S. Wainscoat
Journal: Blood
Blood (2000) 96 (1): 358–361.
https://doi.org/10.1182/blood.V96.1.358
Published: 2000